$14.14 -0.20 (-1.39%)
11/27/2009 1:01 PM

Biovail Corp (USA) (BVF)

CAPS Rating: 4 out of 5

A specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. Its main therapeutic areas are central nervous system disorders, pain management and cardiovascular disease.

Featured Broker Partners